Related references
Note: Only part of the references are listed.Marginal Impact of Brown Seaweed Ascophyllum nodosum and Fucus vesiculosus Extract on Metabolic and Inflammatory Response in Overweight and Obese Prediabetic Subjects
Marlene Vodouhe et al.
MARINE DRUGS (2022)
A Nutraceutical Formulation Containing Brown Algae Reduces Hepatic Lipid Accumulation by Modulating Lipid Metabolism and Inflammation in Experimental Models of NAFLD and NASH
Daniela Gabbia et al.
MARINE DRUGS (2022)
Dietary iodine, seaweed consumption, and incidence risk of metabolic syndrome among postmenopausal women: a prospective analysis of the Korean Multi-Rural Communities Cohort Study (MRCohort)
Jin-Kyu Park et al.
EUROPEAN JOURNAL OF NUTRITION (2021)
Brown Algae Potential as a Functional Food against Hypercholesterolemia: Review
Rebeca Andre et al.
FOODS (2021)
Effects of Ingesting Fucoidan Derived from Cladosiphon okamuranus Tokida on Human NK Cells: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Pilot Study
Makoto Tomori et al.
MARINE DRUGS (2021)
Effects of Daily Kelp (Laminaria japonica) Intake on Body Composition, Serum Lipid Levels, and Thyroid Hormone Levels in Healthy Japanese Adults: A Randomized, Double-Blind Study
Seiichiro Aoe et al.
MARINE DRUGS (2021)
Composition, isolation, purification and biological activities of Sargassum fusiforme polysaccharides: A review
Rui Zhang et al.
CARBOHYDRATE POLYMERS (2020)
Mechanisms underlying direct actions of hyperlipidemia on myocardium: an updated review
Yu Si Yao et al.
LIPIDS IN HEALTH AND DISEASE (2020)
The reporting quality and risk of bias of randomized controlled trials of acupuncture for migraine: Methodological study based on STRICTA and RoB 2.0
Tingting Lu et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2020)
Nutraceutical characteristics of the brown seaweed carotenoid fucoxanthin
Kazuo Miyashita et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2020)
Cardiovascular Risk and Statin Therapy Considerations in Women
Gina Gheorghe et al.
DIAGNOSTICS (2020)
Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis
Sabya Sachi Das et al.
POLYMERS (2020)
Brown Seaweeds for the Management of Metabolic Syndrome and Associated Diseases
Daniela Gabbia et al.
MOLECULES (2020)
Dietary Patterns in Relation to Components of Dyslipidemia and Fasting Plasma Glucose in Adults with Dyslipidemia and Elevated Fasting Plasma Glucose in Taiwan
Li-Yin Lin et al.
NUTRIENTS (2019)
Seaweed intake and risk of cardiovascular disease: the Japan Public Health Center-based Prospective (JPHC) Study
Utako Murai et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options
Adam N. Berman et al.
CURRENT CARDIOLOGY REPORTS (2019)
Ascophyllum Nodosum, Fucus Vesiculosus and chromium picolinate nutraceutical composition can help to treat type 2 diabetic patients
Giuseppe Derosa et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2019)
Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP)
Sampson Opoku et al.
BMC PUBLIC HEALTH (2019)
A Randomized Placebo-controlled Trial of an Oral Preparation of High Molecular Weight Fucoidan in Patients with Type 2 Diabetes with Evaluation of Taste Sensitivity
Chieko Sakai et al.
YONAGO ACTA MEDICA (2019)
Randomized, Double-Blind, Crossover Clinical Trial of the Effect of Calcium Alginate in Noodles on Postprandial Blood Glucose Level
Takako Kato et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2018)
Quantifying the effects of spirulina supplementation on plasma lipid and glucose concentrations, body weight, and blood pressure
Haohai Huang et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2018)
Reduction of HbA1c levels by fucoxanthin-enriched akamoku oil possibly involves the thrifty allele of uncoupling protein 1 (UCP1): a randomised controlled trial in normal-weight and obese Japanese adults
Nana Mikami et al.
JOURNAL OF NUTRITIONAL SCIENCE (2017)
Fucoidan alleviates high-fat diet-induced dyslipidemia and atherosclerosis in ApoEShl mice deficient in apolipoprotein E expression
Takashi Yokota et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2016)
Fucoidan improves serum lipid levels and atherosclerosis through hepatic SREBP-2-mediated regulation
Jinhee Park et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2016)
Clinical Trial of the Hypolipidemic Effects of a Brown Alga Ecklonia cava Extract in Patients with Hypercholesterolemia
Eun-Kyung Choi et al.
INTERNATIONAL JOURNAL OF PHARMACOLOGY (2015)
Serum lipids and associated factors of dyslipidemia in the adult population in Shenzhen
Wen-Qing Ni et al.
LIPIDS IN HEALTH AND DISEASE (2015)
Seaweeds as Preventive Agents for Cardiovascular Diseases: From Nutrients to Functional Foods
Susana M. Cardoso et al.
MARINE DRUGS (2015)
A review of potential metabolic etiologies of the observed association between red meat consumption and development of type 2 diabetes mellitus
Yoona Kim et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Hypolipidaemic potential of seaweeds in normal, triton-induced and high-fat diet-induced hyperlipidaemic rats
Khan Ruqqia et al.
JOURNAL OF APPLIED PHYCOLOGY (2015)
Structure and hypolipidaemic activity of fucoidan extracted from brown seaweed Sargassum henslowianum
Ho Duc Cuong et al.
NATURAL PRODUCT RESEARCH (2015)
Comparison of red, brown and green seaweeds on enzymatic saccharification process
In Kwon Hong et al.
JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY (2014)
Effect of Fucoidan Administration on Insulin Secretion and Insulin Resistance in Overweight or Obese Adults
Diana M. Hernandez-Corona et al.
JOURNAL OF MEDICINAL FOOD (2014)
Effects of dietary fucoxanthin on cholesterol metabolism in diabetic/obese KK-Ay mice
Fumiaki Beppu et al.
LIPIDS IN HEALTH AND DISEASE (2012)
Hypolipidemic effect of fucoidan from Laminaria japonica in hyperlipidemic rats
Ling Huang et al.
PHARMACEUTICAL BIOLOGY (2010)
Effects of seaweed supplementation on blood glucose concentration, lipid profile, and antioxidant enzyme activities in patients with type 2 diabetes mellitus
Min Sun Kim et al.
Nutrition Research and Practice (2009)
Anti-hyperlipidemic effect of an edible brown algae, Ecklonia stolonifera, and its constituents on poloxamer 407-induced hyperlipidemic and cholesterol-fed rats
Na Young Yoon et al.
ARCHIVES OF PHARMACAL RESEARCH (2008)
Binding of bile salts to soluble and insoluble dietary fibers of seaweeds
W Wang et al.
FISHERIES SCIENCE (2001)
Dietary fibre from edible seaweeds:: chemical structure, physicochemical properties and effects on cholesterol metabolism
A Jiménez-Escrig et al.
NUTRITION RESEARCH (2000)
Share Paper
